These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 29725371)

  • 1. Analyses of risk factors for polycystic ovary syndrome complicated with non-alcoholic fatty liver disease.
    Zhang J; Hu J; Zhang C; Jiao Y; Kong X; Wang W
    Exp Ther Med; 2018 May; 15(5):4259-4264. PubMed ID: 29725371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of resolving method of Chinese medicine on the lipid metabolism in polycystic ovary syndrome accompanied with non-alcoholic fatty liver disease].
    Chen Y; Wang XJ; Jin HL; Jin L
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Jun; 33(6):751-6. PubMed ID: 23980352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
    Li X; Lin JF
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Exploration of the classification of polycystic ovarian syndrome].
    Lin JF; Li X; Zhu MW
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic disparities between obese and non-obese patients with polycystic ovary syndrome: implications for endometrial receptivity indicators.
    Li XL; Ji YF; Feng Y; Liu SW
    Gynecol Endocrinol; 2024 Dec; 40(1):2312895. PubMed ID: 38444321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled attenuation parameters to assess liver steatosis in obese patients with polycystic ovary syndrome.
    Wang D; Nan N; Bing H; He B
    Front Endocrinol (Lausanne); 2023; 14():1241734. PubMed ID: 37720537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome.
    Macut D; Tziomalos K; Božić-Antić I; Bjekić-Macut J; Katsikis I; Papadakis E; Andrić Z; Panidis D
    Hum Reprod; 2016 Jun; 31(6):1347-53. PubMed ID: 27076501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum uric acid/creatinine ratio and free androgen index are synergistically associated with increased risk of polycystic ovary syndrome in obese women.
    El-Eshmawy MM; Ibrahim A; Bahriz R; Shams-Eldin N; Mahsoub N
    BMC Endocr Disord; 2022 Dec; 22(1):315. PubMed ID: 36514085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex Hormone-Binding Globulin (SHBG) Reduction: The Alarm Bell for the Risk of Non-Alcoholic Fatty Liver Disease in Adolescents with Polycystic Ovary Syndrome.
    Urbano F; Chiarito M; Lattanzio C; Messa A; Ferrante M; Francavilla M; Mehmeti I; Lassandro G; Giordano P; Faienza MF
    Children (Basel); 2022 Nov; 9(11):. PubMed ID: 36421197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Serum Omentin, CTRP9, and Vaspin in Patients with Polycystic Ovary Syndrome.
    Wang Y; Liu N; Lu J; Yang L; Wang C; Chen J; Chang W
    Evid Based Complement Alternat Med; 2022; 2022():1862404. PubMed ID: 36034953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.
    Holte J; Bergh T; Gennarelli G; Wide L
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on the correlation between different Chinese medicine syndrome types and endocrine metabolism of polycystic ovarian syndrome].
    Wang XJ; Zeng XL; Liu Y
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Aug; 31(8):1085-9. PubMed ID: 21910340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acupuncture Treatment of Polycystic Ovarian Syndrome Patients with Abdominal Obesity by Regulating Dai Meridian: A Randomized Controlled Clinical Trial].
    Shen LY; Liang CM; Yang WJ; Pan L; Li H; Hu H
    Zhen Ci Yan Jiu; 2018 Apr; 43(4):255-9. PubMed ID: 29888581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical study on treating insulin resistance and promoting ovulation in polycystic ovary syndrome].
    Liu ZA; Xue YM; Chen LX; Cai Q; Chen H; Zhang J; Cui QH; Ge J; Yuan T
    Zhonghua Fu Chan Ke Za Zhi; 2004 Sep; 39(9):586-90. PubMed ID: 15498183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-free androgen index is associated with increased risk of non-alcoholic fatty liver disease in women with polycystic ovary syndrome, independent of obesity and insulin resistance.
    Cai J; Wu CH; Zhang Y; Wang YY; Xu WD; Lin TC; Li SX; Wang LH; Zheng J; Sun Y; Liu W; Tao T
    Int J Obes (Lond); 2017 Sep; 41(9):1341-1347. PubMed ID: 28487551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Androgen Levels, Endocrine and Metabolic Indices, and Clinical Findings in Women with Polycystic Ovary Syndrome in Uygur and Han Ethnic Groups from Xinjiang Province in China.
    Zhao H; Song X; Zhang L; Xu Y; Wang X
    Med Sci Monit; 2018 Sep; 24():6774-6780. PubMed ID: 30252834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of abdominal acupuncture therapy on the endocrine and metabolism in obesity-type polycystic ovarian syndrome patients].
    Lai MH; Ma HX; Yao H; Liu H; Song XH; Huang WY; Wu XK
    Zhen Ci Yan Jiu; 2010 Aug; 35(4):298-302. PubMed ID: 21090334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study.
    Singh S; Akhtar N; Ahmad J
    Diabetes Metab Syndr; 2012; 6(4):207-11. PubMed ID: 23199540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the significance of sex hormone-binding globulin examination in the treament of women with polycystic ovarian syndrome (PCOS).
    Lin XF; Wu RR; Du J; Liao YC; Du Y; Ye Y; Wang Y; Zhang XB; Wu C; Chen A
    Clin Exp Obstet Gynecol; 2015; 42(3):315-20. PubMed ID: 26152001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-alcoholic fatty liver disease in women with polycystic ovary syndrome - clinical and metabolic aspects and lipoprotein lipase gene polymorphism.
    Bohdanowicz-Pawlak A; Lenarcik-Kabza A; Brona A; Kuliczkowska-Płaksej J; Łaczmański Ł; Zaleska-Dorobisz U; Milewicz A
    Endokrynol Pol; 2014; 65(6):416-21. PubMed ID: 25554608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.